Evolent Health (STU:9EH) 3-Year Revenue Growth Rate : 17.50% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evolent Health 3-Year Revenue Growth Rate?

Evolent Health's Revenue per Share for the three months ended in Mar. 2024 was €5.16.

During the past 12 months, Evolent Health's average Revenue per Share Growth Rate was 29.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 17.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Evolent Health was 103.30% per year. The lowest was 9.20% per year. And the median was 17.50% per year.

Competitive Comparison of Evolent Health's 3-Year Revenue Growth Rate

For the Health Information Services subindustry, Evolent Health's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolent Health's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Evolent Health's 3-Year Revenue Growth Rate falls into.

Evolent Health 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Evolent Health (STU:9EH) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Evolent Health 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Evolent Health's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health (STU:9EH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

EVH:USA

Address

800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Evolent Health (STU:9EH) Headlines

No Headlines